Skip to main content
BioSyent Inc. logo

BioSyent Inc. — Investor Relations & Filings

Ticker · RX ISIN · CA0906901081 TSXV Manufacturing
Open in API
Filings indexed 411 across all filing types
Latest filing 2020-05-28 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV RX

About BioSyent Inc.

https://www.biosyent.com/

BioSyent Inc. is a profitable, growth-oriented specialty pharmaceutical company focused on enhancing patient lives by addressing unmet medical needs. The company's primary business model involves sourcing, in-licensing, and acquiring innovative pharmaceutical and healthcare products globally for development and commercialization. BioSyent markets a diverse portfolio of products, including prescription, over-the-counter, and behind-the-counter options, primarily serving markets in Canada and select international regions.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a press release dated May 28, 2020, announcing BioSyent Inc.'s financial results for the first quarter ended March 31, 2020. It includes detailed financial highlights such as net revenues, EBITDA, net income, EPS, and balance sheet data. The document also mentions that the company's Interim Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the quarter will be posted on SEDAR. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year, specifically the first quarter, indicates this is an Interim / Quarterly Report. The document is longer than 5,000 characters and contains substantive financial data, so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2020
2020-05-28 English
News release - English.pdf
Regulatory Filings
2020-05-21 English
Management information circular - English.pdf
AGM Information Classification · 100% confidence The document is titled as a "Notice of Annual General and Special Meeting of Shareholders" and includes an "Information Circular" dated April 13, 2020. It details the agenda for the annual general meeting (AGM), including receiving audited financial statements, electing directors, appointing auditors, and approving stock option plans. It also contains proxy solicitation information and voting instructions for shareholders. The content is typical of materials distributed to shareholders ahead of an AGM to inform them about meeting logistics and matters to be voted on. There is no actual financial data or report content, only notice and proxy information. Therefore, this document is best classified as AGM Information (AGM-R).
2020-05-06 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for an Annual General and Special Meeting scheduled for May 27, 2020. It includes instructions for voting, appointment of proxyholders, and voting recommendations for election of directors and appointment of auditors. The content is focused on soliciting votes and providing proxy voting instructions rather than presenting financial data or detailed company reports. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the meeting.
2020-05-06 English
Other.pdf
AGM Information Classification · 95% confidence The document is a Voting Instruction Form (VIF) related to an Annual General and Special Meeting scheduled for May 27, 2020. It contains detailed instructions for shareholders on how to vote, appoint proxies, and the voting recommendations for the meeting. The content is focused on proxy voting procedures and shareholder instructions rather than the actual meeting materials or results. This type of document is typically part of proxy solicitation materials or voting instruction forms associated with AGMs. Given the detailed voting instructions and the context of an AGM, the document fits best under AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. It is not a report, announcement of voting results, or a proxy statement itself, but closely related to AGM materials.
2020-05-06 English
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a notice of the Annual General and Special Meeting of Shareholders for BioSyent Inc. It outlines the meeting agenda including receiving audited financial statements, electing directors, appointing auditors, and approving stock option plans. It is a formal announcement inviting shareholders to the meeting and providing procedural details, but it does not contain the actual financial statements or detailed reports. The document length is short (3099 characters) and it serves as a meeting notice rather than the report itself. Therefore, it fits the definition of AGM Information (AGM-R).
2020-05-06 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.